disease epidemic displaced Sudanese population visceral leishmaniasis fatal disease Bentiu area southern Sudan mass migration Nuer tribe treatment available information high mortality rate due possible occurrence tuberculosis malaria enteric fever visceral leishmaniasis VL Serological screening affected patients enzyme-linked immunosorbent assay ELISA improved direct agglutination test DAT positivity VL patients diagnosis identification Leishmania donovani amastigotes lymph node bone-marrow aspirates total patients clinical symptoms VL DAT positive titers equal Forty-two VL cases treatment mortality rate intercurrent infections VL population respiratory involvements malaria prevalent exception VL patients stibogluconate factors outbreak Malnutrition nomadic movements potential VL endemic areas important HIV infection possible predisposition remote clinical epidemiological similarity VL East Africa adequate humoral response DAT immediate positive response specific anti-Leishmania chemotherapy 